This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
2 Known Drug Interactions — Some May Be Serious
1 Moderate1 Mild
This herb may interact with medications you are taking. Review the interactions table below and consult your healthcare provider before use.
What is a herb–drug interaction?
A herb–drug interaction happens when a plant or supplement changes how a medication works in your body — making it stronger, weaker, or more likely to cause harm. Herbs contain active compounds that can speed up or slow down the enzymes and transporters your body uses to process drugs.
Why it matters
•St. John's Wort can make birth control, antidepressants, and blood thinners less effective.
•Garlic can increase bleeding risk with warfarin and other blood thinners (also ginkgo, ginger, and turmeric).
•Kava can amplify sedation when taken with anxiety or sleep medications (also valerian).
The risk is highest for older adults, anyone taking several medications, and people with chronic conditions.
Always tell your doctor and pharmacist about every herb and supplement you take — and check below before combining.
Known Drug Interactions (2)
1 Moderate1 Mild
Drug
Severity
Description
Thyroid medications (Levothyroxine)
Moderate
Bacopa may increase thyroid hormone levels, potentially causing excess thyroid activity in medicated patients.
Calcium channel blockers
Mild
Bacopa may have mild calcium channel blocking effects that add to antihypertensive medications.
This list reflects a curated subset of documented interactions and is not exhaustive. The absence of a drug here is not proof that it is safe to combine. Always confirm with a pharmacist or healthcare provider.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 28 PubMed articles · model: gemma4:31b
Summary
Bacopa monnieri is a plant-derived nootropic used to improve language, learning, and memory [PMID:34978226], and is recognized for its neuroprotective and cognitive-enhancing effects [PMID:36943953].
Background
Bacopa monnieri, also known as Brahmi or Water Hyssop, is a perennial creeping aquatic herb native to the Indian subcontinent [PMID:38718157, PMID:38500283, PMID:35775276].
Traditional uses
In Ayurvedic medicine, it has been used for centuries as a memory and learning enhancer, sedative, anti-epileptic, anxiolytic, and treatment for insomnia [PMID:36061899, PMID:38718157, PMID:36943953].
Active compounds
The primary active compounds are dammarane-type triterpenoid saponins known as bacosides (including Bacoside A and B) [PMID:31622587, PMID:35201388]. Other identified constituents include alkaloids, flavonoids, glycosides, betulinic acid, asiatic acid, loliolide, ebelin lactone, quercetin, and cucurbitacins (bacobitacin A-D and cucurbitacin E) [PMID:33675463, PMID:35043757, PMID:17442350, PMID:40507208].
Mechanism of action
Bacopa may modulate neurotransmission, neurogenesis, neuronal/glial plasticity, and intracellular signaling [PMID:35043757]. It promotes free radical scavenger mechanisms, reduces lipoxygenase activity to decrease lipid peroxidation, increases glutathione peroxidase, and chelates iron [PMID:28588366]. It is also associated with reducing hippocampal β-amyloid deposition and protecting cholinergic neurons [PMID:28588366].
Clinical evidence
Evidence ACognition (General)
Improves language, learning, and memory [PMID:34978226].
Evidence AADHD
Consistently improved inattention, hyperactivity, and memory [PMID:40362791].
Evidence BMild Cognitive Impairment
A triple-blinded RCT of 160 mg extract over 2 months showed no significant results in cognitive performance and sleep quality [PMID:38538390].
Evidence BElderly Cognition
A randomized double-blind placebo-controlled trial evaluated 300 mg/day for 12 weeks in healthy elderly participants [PMID:18611150].
Evidence CAlzheimer's Disease
Human studies on patients with Alzheimer's Disease have been inconclusive [PMID:36936504].
Safety & adverse effects
Bacopa is generally well-tolerated with a high therapeutic index [PMID:36943953]. Common side effects are gastrointestinal, including nausea, abdominal cramps, and increased stool frequency [PMID:36943953]. It has not been linked to liver enzyme elevations or acute liver injury [PMID:38718157].
Pregnancy & lactation
Further research is needed to ensure safety, especially for pregnant and breastfeeding women [PMID:40507208].
Drug interactions
Interactions with certain medications should be considered [PMID:40507208].
Evidence summary
Evidence is strongest (Level A) for improvements in general cognition and ADHD symptoms. Evidence for specific neurodegenerative diseases like Alzheimer's remains inconclusive in humans despite promising preclinical data, and some specific trials for mild cognitive impairment have shown no effect.
PubMed sources
1.PMID: 34978226 (2023) — Plant-derived nootropics and human cognition: A systematic review. · Critical reviews in food science and nutrition
2.PMID: 36061899 (2022) — Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation. · Frontiers in nutrition
3.PMID: 38718157 (2012) — Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. · Journal of ethnopharmacology
4.PMID: 36987052 (2023) — Nootropic Herbs, Shrubs, and Trees as Potential Cognitive Enhancers. · Plants (Basel, Switzerland)
5.PMID: 36943953 (2026) — Investigating the Neuroprotective and Cognitive-Enhancing Effects of Bacopa monnieri: A Systematic Review Focused on Inflammation, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 18611150 (2008) — Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. · Journal of alternative and complementary medicine (New York, N.Y.)
7.PMID: 40362791 (2025) — Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review. · Nutrients
8.PMID: 31622587 (2019) — Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease. · Archives of biochemistry and biophysics
9.PMID: 38538390 (2024) — Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial. · Explore (New York, N.Y.)
10.PMID: 33675463 (2021) — Neuroprotection with Bacopa monnieri-A review of experimental evidence. · Molecular biology reports
11.PMID: 28588366 (2017) — Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer's Disease. · Annals of neurosciences
12.PMID: 38500283 (2024) — Investigating Bacopa monnieri L. Therapeutic Potential for the Treatment of Neurological Diseases. · Current pharmaceutical design
13.PMID: 36936504 (2023) — Importance of high-quality evidence regarding the use of Bacopa monnieri in dementia. · Frontiers in aging neuroscience
14.PMID: 33148034 (2021) — The Evolving Roles of Bacopa monnieri as Potential Anti-Cancer Agent: A Review. · Nutrition and cancer
15.PMID: 22074576 (2011) — Exploring the Role of “Brahmi” (Bacopa monnieri and Centella asiatica) in Brain Function and Therapy. · Recent patents on endocrine, metabolic & immune drug discovery
16.PMID: 39498770 (2025) — Effectiveness of Bacopa Monnieri (Brahmi) in the management of schizophrenia: a systematic review. · Nutritional neuroscience
17.PMID: 35043757 (2022) — Bacopa monnieri for Disorders Affecting Brain: Current Perspectives. · Current topics in medicinal chemistry
18.PMID: 35775276 (2023) — TiO2 nanoparticle synthesis, characterization and application to shoot regeneration of water hyssop (Bacopa monnieri L. Pennel) in vitro. · Biotechnic & histochemistry : official publication of the Biological Stain Commission
19.PMID: 31863386 (2020) — Ability of Indian pennywort Bacopa monnieri (L.) Pennell in the phytoremediation of sewage (greywater). · Environmental science and pollution research international
20.PMID: 35201388 (2022) — Biotechnological production of bacosides from cell and organ cultures of Bacopa monnieri. · Applied microbiology and biotechnology
21.PMID: 41305589 (2025) — The Role of Bacopa monnieri in Alzheimer's Disease: Mechanisms and Potential Clinical Use-A Review. · Nutrients
22.PMID: 39959708 (2025) — Exploring therapeutic potential of Bacopa monnieri bioactive compounds against Alzheimer's and Parkinson's diseases. · 3 Biotech
23.PMID: 26973531 (2016) — The Molecular Links of Re-Emerging Therapy: A Review of Evidence of Brahmi (Bacopa monniera). · Frontiers in pharmacology
24.PMID: 34254371 (2021) — Bacosides from Bacopa monnieri extract: An overview of the effects on neurological disorders. · Phytotherapy research : PTR
25.PMID: 35692129 (2022) — Ameliorative Effects of Phytomedicines on Alzheimer's Patients. · Current Alzheimer research
26.PMID: 34315377 (2021) — The Safety and Efficacy of Botanicals with Nootropic Effects. · Current neuropharmacology
27.PMID: 17442350 (2007) — Cucurbitacins from Bacopa monnieri. · Phytochemistry
28.PMID: 40507208 (2025) — Bacopa monnieri: Preclinical and Clinical Evidence of Neuroactive Effects, Safety of Use and the Search for Improved Bioavailability. · Nutrients